Phase II study of olaparib in patients with refractory Ewing sarcoma following failure of standard chemotherapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Phase II study of olaparib in patients with refractory Ewing sarcoma following failure of standard chemotherapy ; volume:14 ; number:1 ; day:5 ; month:11 ; year:2014 ; pages:1-6 ; date:12.2014
BMC cancer ; 14, Heft 1 (5.11.2014), 1-6, 12.2014
- Creator
-
Choy, Edwin
- Contributor
-
Butrynski, James E.
Harmon, David C.
Morgan, Jeffrey A.
George, Suzanne
Wagner, Andrew J.
D’Adamo, David
Cote, Gregory M.
Flamand, Yael
Benes, Cyril H.
Haber, Daniel A.
Baselga, Jose M.
Demetri, George D.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-14-813
- URN
-
urn:nbn:de:1111-2016030414398
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Choy, Edwin
- Butrynski, James E.
- Harmon, David C.
- Morgan, Jeffrey A.
- George, Suzanne
- Wagner, Andrew J.
- D’Adamo, David
- Cote, Gregory M.
- Flamand, Yael
- Benes, Cyril H.
- Haber, Daniel A.
- Baselga, Jose M.
- Demetri, George D.
- SpringerLink (Online service)
Other Objects (12)
Alternative Chemotherapy Schedules in Ewing's Sarcoma: An Indian Perspective
Non-chemotherapy adjuvant agents in TP53 mutant Ewing sarcoma
Atypical Presentation of Ewing’s Sarcoma
Ewing’s Sarcoma of the Calcaneum
Cutaneous Ewing Sarcoma and Ewing Sarcoma of the Bone: Distinct Diseases
Cavernous Sinus Ewing's Sarcoma
Ewing’s Sarcoma of the Cranial Vault
Maturation toward neuronal tissue in a Ewing sarcoma of bone after chemotherapy
Potential molecular targets for Ewing′s sarcoma therapy
Co-targeting JAK1/STAT6/GAS6/TAM signaling improves chemotherapy efficacy in Ewing sarcoma
Sinonasal FUS-ERG-Rearranged Ewing’s Sarcoma Mimicking Glomangiopericytoma
Atypical Presentation of Primary Ewing's Sarcoma
Alternative Chemotherapy Schedules in Ewing's Sarcoma: An Indian Perspective
Non-chemotherapy adjuvant agents in TP53 mutant Ewing sarcoma
Atypical Presentation of Ewing’s Sarcoma
Ewing’s Sarcoma of the Calcaneum
Cutaneous Ewing Sarcoma and Ewing Sarcoma of the Bone: Distinct Diseases
Cavernous Sinus Ewing's Sarcoma
Ewing’s Sarcoma of the Cranial Vault
Maturation toward neuronal tissue in a Ewing sarcoma of bone after chemotherapy
Potential molecular targets for Ewing′s sarcoma therapy
Co-targeting JAK1/STAT6/GAS6/TAM signaling improves chemotherapy efficacy in Ewing sarcoma
Sinonasal FUS-ERG-Rearranged Ewing’s Sarcoma Mimicking Glomangiopericytoma
Atypical Presentation of Primary Ewing's Sarcoma
Alternative Chemotherapy Schedules in Ewing's Sarcoma: An Indian Perspective
Non-chemotherapy adjuvant agents in TP53 mutant Ewing sarcoma
Atypical Presentation of Ewing’s Sarcoma
Ewing’s Sarcoma of the Calcaneum
Cutaneous Ewing Sarcoma and Ewing Sarcoma of the Bone: Distinct Diseases
Cavernous Sinus Ewing's Sarcoma
Ewing’s Sarcoma of the Cranial Vault
Maturation toward neuronal tissue in a Ewing sarcoma of bone after chemotherapy
Potential molecular targets for Ewing′s sarcoma therapy
Co-targeting JAK1/STAT6/GAS6/TAM signaling improves chemotherapy efficacy in Ewing sarcoma
Sinonasal FUS-ERG-Rearranged Ewing’s Sarcoma Mimicking Glomangiopericytoma